Literature DB >> 29146382

On the bias of estimates of influenza vaccine effectiveness from test-negative studies.

Kylie E C Ainslie1, Meng Shi1, Michael Haber2, Walter A Orenstein3.   

Abstract

Estimates of the effectiveness of influenza vaccines are commonly obtained from a test-negative design (TND) study, where cases and controls are patients seeking care for an acute respiratory illness who test positive and negative, respectively, for influenza infection. Vaccine effectiveness (VE) estimates from TND studies are usually interpreted as vaccine effectiveness against medically-attended influenza (MAI). However, it is also important to estimate VE against any influenza illness (symptomatic influenza (SI)) as individuals with SI are still a public health burden even if they do not seek medical care. We present a numerical method to evaluate the bias of TND-based estimates of influenza VE with respect to MAI and SI. We consider two sources of bias: (a) confounding bias due to a (possibly unobserved) covariate that is associated with both vaccination and the probability of the outcome of interest and (b) bias resulting from the effect of vaccination on the probability of seeking care. Our results indicate that (a) VE estimates may suffer from substantial confounding bias when a confounder has a different effect on the probabilities of influenza and non-influenza ARI, and (b) when vaccination reduces the probability of seeking care against influenza ARI, then estimates of VE against MAI may be unbiased while estimates of VE against SI may be have a substantial positive bias.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bias; Influenza; Test-negative design; Vaccine effectiveness

Mesh:

Substances:

Year:  2017        PMID: 29146382      PMCID: PMC5712239          DOI: 10.1016/j.vaccine.2017.10.107

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  19 in total

1.  Moderate influenza vaccine effectiveness in Victoria, Australia, 2011.

Authors:  J E Fielding; K A Grant; T Tran; H A Kelly
Journal:  Euro Surveill       Date:  2012-03-15

2.  The case test-negative design for studies of the effectiveness of influenza vaccine.

Authors:  Ivo M Foppa; Michael Haber; Jill M Ferdinands; David K Shay
Journal:  Vaccine       Date:  2013-04-23       Impact factor: 3.641

3.  Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis.

Authors:  J Castilla; I Martínez-Baz; A Navascués; M Fernandez-Alonso; G Reina; M Guevara; J Chamorro; M T Ortega; E Albéniz; F Pozo; C Ezpeleta
Journal:  Euro Surveill       Date:  2014-02-13

Review 4.  Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies.

Authors:  Edward A Belongia; Melissa D Simpson; Jennifer P King; Maria E Sundaram; Nicholas S Kelley; Michael T Osterholm; Huong Q McLean
Journal:  Lancet Infect Dis       Date:  2016-04-06       Impact factor: 25.071

5.  Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness.

Authors:  Sheena G Sullivan; Eric J Tchetgen Tchetgen; Benjamin J Cowling
Journal:  Am J Epidemiol       Date:  2016-09-01       Impact factor: 4.897

6.  Influenza vaccine effectiveness in Australia: results from the Australian Sentinel Practices Research Network.

Authors:  Sheena G Sullivan; Monique B-N Chilver; Geoff Higgins; Allen C Cheng; Nigel P Stocks
Journal:  Med J Aust       Date:  2014-07-21       Impact factor: 7.738

7.  Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness.

Authors:  Evan W Orenstein; Gaston De Serres; Michael J Haber; David K Shay; Carolyn B Bridges; Paul Gargiullo; Walter A Orenstein
Journal:  Int J Epidemiol       Date:  2007-04-02       Impact factor: 7.196

8.  The test-negative design for estimating influenza vaccine effectiveness.

Authors:  Michael L Jackson; Jennifer C Nelson
Journal:  Vaccine       Date:  2013-03-13       Impact factor: 3.641

9.  Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza.

Authors:  Jesús Castilla; Pere Godoy; Angela Domínguez; Iván Martínez-Baz; Jenaro Astray; Vicente Martín; Miguel Delgado-Rodríguez; Maretva Baricot; Nuria Soldevila; José María Mayoral; José María Quintana; Juan Carlos Galán; Ady Castro; Fernando González-Candelas; Olatz Garín; Marc Saez; Sonia Tamames; Tomás Pumarola
Journal:  Clin Infect Dis       Date:  2013-03-26       Impact factor: 9.079

10.  Vaccine-associated reduction in symptom severity among patients with influenza A/H3N2 disease.

Authors:  Robert G Deiss; John C Arnold; Wei-Ju Chen; Sara Echols; Mary P Fairchok; Christina Schofield; Patrick J Danaher; Erin McDonough; Michelande Ridoré; Deepika Mor; Timothy H Burgess; Eugene V Millar
Journal:  Vaccine       Date:  2015-11-10       Impact factor: 3.641

View more
  10 in total

1.  Measurement of Vaccine Direct Effects Under the Test-Negative Design.

Authors:  Joseph A Lewnard; Christine Tedijanto; Benjamin J Cowling; Marc Lipsitch
Journal:  Am J Epidemiol       Date:  2018-12-01       Impact factor: 4.897

2.  Bias of influenza vaccine effectiveness estimates from test-negative studies conducted during an influenza pandemic.

Authors:  Kylie E C Ainslie; Michael Haber; Walter A Orenstein
Journal:  Vaccine       Date:  2019-03-02       Impact factor: 3.641

3.  Challenges in estimating influenza vaccine effectiveness.

Authors:  Kylie E C Ainslie; Michael Haber; Walt A Orenstein
Journal:  Expert Rev Vaccines       Date:  2019-05-31       Impact factor: 5.217

4.  The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology.

Authors:  Huiying Chua; Shuo Feng; Joseph A Lewnard; Sheena G Sullivan; Christopher C Blyth; Marc Lipsitch; Benjamin J Cowling
Journal:  Epidemiology       Date:  2020-01       Impact factor: 4.822

5.  Potential test-negative design study bias in outbreak settings: application to Ebola vaccination in Democratic Republic of Congo.

Authors:  Carl A B Pearson; W John Edmunds; Thomas J Hladish; Rosalind M Eggo
Journal:  Int J Epidemiol       Date:  2022-02-18       Impact factor: 7.196

Review 6.  Immune History and Influenza Vaccine Effectiveness.

Authors:  Joseph A Lewnard; Sarah Cobey
Journal:  Vaccines (Basel)       Date:  2018-05-21

7.  Effect of seasonal influenza vaccination on influenza symptom severity among children in Hutterite communities: Follow-up study of a randomized trial.

Authors:  Shannon E Brent; Eleanor Pullenayegum; Margaret L Russell; Mark Loeb
Journal:  Influenza Other Respir Viruses       Date:  2019-11-08       Impact factor: 4.380

8.  Impact of influenza vaccination on amoxicillin prescriptions in older adults: A retrospective cohort study using primary care data.

Authors:  Lauren R Rodgers; Adam J Streeter; Nan Lin; Willie Hamilton; William E Henley
Journal:  PLoS One       Date:  2021-01-29       Impact factor: 3.240

Review 9.  Assessment of the benefits of seasonal influenza vaccination: Elements of a framework to interpret estimates of vaccine effectiveness and support robust decision-making and communication.

Authors:  Rosalind Hollingsworth; Clotilde El Guerche-Séblain; Theodore Tsai; Yuri Vasiliev; Sam Lee; Helen Bright; Paula Barbosa
Journal:  Influenza Other Respir Viruses       Date:  2020-09-03       Impact factor: 4.380

10.  Cost of inappropriate antimicrobial use for upper respiratory infection in Japan.

Authors:  Shinya Tsuzuki; Yuki Kimura; Masahiro Ishikane; Yoshiki Kusama; Norio Ohmagari
Journal:  BMC Health Serv Res       Date:  2020-02-28       Impact factor: 2.655

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.